Lilly bets more than $600M on a gene therapy developer targeting hearing loss
A stem cell aging framework, from mechanisms to interventions
Healthy aging and the human gut microbiome: why we cannot just turn back the clock
‘In vivo’ cell therapy: expanding beyond CAR-T
At least five startups have emerged with new ways to genetically modify immune cells within the body, an approach that, if successful, could widen the field of CAR-T treatment.
The debate over whether aging is a disease rages on
In its latest catalogue of health conditions, the World Health Organization almost equated old age with disease. Then it backed off.
First known map of night sky found hidden in Medieval parchment
Fabled star catalogue by ancient Greek astronomer Hipparchus had been feared lost.
Black Death may have influenced evolution of genes involved in immune responses, study finds
The bird is fine, the bird is fine, the bird is fine, it’s dead.
The pursuit of immortality is getting older. So are we.
Nucleome raises £37.5m to shine light on ‘dark genome’
Gilead, working to improve cancer cell therapy, partners with California startup
Synthetic biology technology developed by the startup, Refuge Biotechnologies, could help Gilead produce safer and more effective CAR-T treatments.